ATE377599T1 - Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen - Google Patents

Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen

Info

Publication number
ATE377599T1
ATE377599T1 AT04812380T AT04812380T ATE377599T1 AT E377599 T1 ATE377599 T1 AT E377599T1 AT 04812380 T AT04812380 T AT 04812380T AT 04812380 T AT04812380 T AT 04812380T AT E377599 T1 ATE377599 T1 AT E377599T1
Authority
AT
Austria
Prior art keywords
triazolo
aminopyrazolo
pyrimidines
producing substituted
substituted
Prior art date
Application number
AT04812380T
Other languages
German (de)
English (en)
Inventor
Shen-Chun Kuo
Loc Tran
Pengyi Zhang
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE377599T1 publication Critical patent/ATE377599T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT04812380T 2003-12-01 2004-11-29 Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen ATE377599T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52592503P 2003-12-01 2003-12-01

Publications (1)

Publication Number Publication Date
ATE377599T1 true ATE377599T1 (de) 2007-11-15

Family

ID=34652398

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04812380T ATE377599T1 (de) 2003-12-01 2004-11-29 Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen

Country Status (8)

Country Link
US (3) US7235659B2 (enExample)
EP (1) EP1689749B1 (enExample)
JP (1) JP2007513091A (enExample)
AT (1) ATE377599T1 (enExample)
CA (1) CA2547248A1 (enExample)
DE (1) DE602004009962T2 (enExample)
ES (1) ES2293380T3 (enExample)
WO (1) WO2005054245A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02011625A (es) * 2000-05-26 2003-03-27 Schering Corp Antagonistas receptores de adenosina a2a.
JP4782693B2 (ja) * 2003-10-28 2011-09-28 シェーリング コーポレイション 置換5−アミノ−ピラゾロ−[4,3−e]−1,2,4−トリアゾロ[1,5−c]ピリミジンを調製するためのプロセス
EP2258372B8 (en) 2005-06-07 2012-12-19 Kyowa Hakko Kirin Co., Ltd. A2A antagonists for use in the treatment of motor disorders
ES2273599B1 (es) 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
US8188098B2 (en) 2008-05-19 2012-05-29 Hoffmann-La Roche Inc. GPR119 receptor agonists
WO2010114894A1 (en) 2009-03-31 2010-10-07 Arqule, Inc. Substituted heterocyclic compounds
WO2012127472A1 (en) * 2011-03-22 2012-09-27 Mapi Pharma Ltd. Process and intermediates for the preparation of preladenant and related compounds
WO2012129381A1 (en) 2011-03-22 2012-09-27 Concert Pharmaceuticals Inc. Deuterated preladenant
WO2013024474A1 (en) * 2011-08-18 2013-02-21 Mapi Phrarma Ltd. Polymorphs of preladenant
US11312719B2 (en) 2018-11-30 2022-04-26 Merck Sharp & Dohme Corp. 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264901B1 (it) * 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
MXPA02011625A (es) * 2000-05-26 2003-03-27 Schering Corp Antagonistas receptores de adenosina a2a.

Also Published As

Publication number Publication date
DE602004009962T2 (de) 2008-08-28
US20090131663A1 (en) 2009-05-21
ES2293380T3 (es) 2008-03-16
WO2005054245A3 (en) 2005-08-11
DE602004009962D1 (de) 2007-12-20
US7507822B2 (en) 2009-03-24
WO2005054245A2 (en) 2005-06-16
JP2007513091A (ja) 2007-05-24
CA2547248A1 (en) 2005-06-16
US20070238874A1 (en) 2007-10-11
US7235659B2 (en) 2007-06-26
US20060149060A1 (en) 2006-07-06
EP1689749B1 (en) 2007-11-07
EP1689749A2 (en) 2006-08-16

Similar Documents

Publication Publication Date Title
CY1106393T1 (el) Μεθοδος παρασκευης υποκατεστημενων 5-αμινο-πυραζολο [4,3-ε]-1,2,4-τριαζολο [1,5-c]πυριμιδινων
NO20053955D0 (no) Pyrazolo [1,5-A] pyrimidinderivater
DE60007257D1 (de) Verfahren zur Herstellung von Cucurbituril Derivaten
SG133602A1 (en) Pyrrolo [2,3-d] pyrimidine compounds for treating transplant rejection
DE50008864D1 (de) Verfahren zur herstellung polyisobutenphenol-haltiger mannichaddukte
IL220174A0 (en) 5-AMINO - {PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE}-2-AND 7-SUBSTITUTED DERIVATIVES AS ADENOSINE A2A RECEPTOR INHIBITORS
ATE377599T1 (de) Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen
IS2843B (is) Pýrróló[3,4-c] pýrasólafleiður virkar sem kínasahindrar
ATE500258T1 (de) Verfahren zur herstellung von olanzapin form i
DE60103416D1 (de) Verfahren zur herstellung von 2-alkoxy-6-trifluoromethyl-n-([1,2,4]triazolo[1,5-c]pyrimidin-2-yl)benzolsulfonamiden
ATE431339T1 (de) Verfahren zur herstellung von n-amino- substituierten heterocyclischen verbindungen
DE60102375D1 (de) Verfahren zur herstellung von 2-amino-5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidine
DE60209011D1 (de) Verfahren zur herstellung von 7-substituierten 3-alkyl-3h-isobenzofuran-1-onderivaten
ATE433965T1 (de) Verfahren zur herstellung von enantiomerenreinem mirtazapin
DE69930416D1 (de) Cgmp pde5 inhibitoren zur inhalationsbehandlung von sexueller dysfunktion
ATE259794T1 (de) Verfahren zur herstellung von 3-hydroxy- tetrahydrofuran
ATE269339T1 (de) Verfahren zur herstellung von (3as)-5,5-dioxo-2,3,3a,4-tetrahydro-1h-pyrrolo( ,1-c)(1,2, 4)benzothiadiazin
DE50103231D1 (de) Verfahren zur herstellung von 7-(pyrazol-3-yl)benzoxazolen
HUP0401991A3 (en) Method for producing of substituted imidazo[1,2-a]-5,6,7,8-tetrahydropyridine-8-on derivatives
DE112004002335D2 (de) Verfahren zur Herstellung von in 2,7-Position substituierten Xanthen-4,5-diolen
ATE395334T1 (de) Verfahren zur herstellung von (3-oxo-2,3-dihydro- 1h-isoindol-1-yl)-acetylguanidin-derivaten
DE60007324D1 (de) Verfahren zur herstellung von diazepinderivaten
ATE413405T1 (de) Verfahren zur herstellung von 3- aminothienopyridon-derivaten
AU2003252509A1 (en) NOVEL PROCESS FOR PRODUCING IMIDAZO(1,2-b)PYRIDAZINE DERIVATIVE
ATE382622T1 (de) Verfahren zur herstellung von triazolopyrimidinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties